Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY AFTER TRAUMATIC BRAIN INJURY, SPINAL CORD INJURY OR IN MULTIPLE SCLEROSIS PATIENTS: AN OBSERVATIONAL STUDY

NCT04673240 is registered in ClinicalTrials.gov with Università degli Studi del Piemonte Orientale Amedeo Avogadro as lead sponsor.

NCT NCT04673240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04673240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY AFTER TRAUMATIC BRAIN INJURY, SPINAL CORD INJURY OR IN MULTIPLE SCLEROSIS PATIENTS: AN OBSERVATIONAL STUDY
Lead sponsor
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Phase
Observational
Overall status
Unknown status
Start date
March 29, 2019
Completion date
June 30, 2022
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, multiple sclerosis, spasticity, spinal cord injuries